These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6896128)

  • 1. [Therapeutic application of vitamin D, its derivatives and analogues (author's transl)].
    Balsan S
    Ann Endocrinol (Paris); 1981; 42(4-5):492-6. PubMed ID: 6896128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative efficacy of various vitamin D metabolites in the treatment of various types of hypoparathyroidism.
    Okano K; Furukawa Y; Morii H; Fujita T
    J Clin Endocrinol Metab; 1982 Aug; 55(2):238-43. PubMed ID: 6979550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of hypoparathyroidism and pseudohypoparathyroidism with metabolites of vitamin D: evidence for impaired conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D.
    Kooh SW; Fraser D; DeLuca HF; Holick MF; Belsey RE; Clark MB; Murray TM
    N Engl J Med; 1975 Oct; 293(17):840-4. PubMed ID: 170516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic use of vitamin D, its derivatives and their analogs].
    Vagneur JP; Argemi B
    Diabete Metab; 1982 Mar; 8(1):65-7. PubMed ID: 6980150
    [No Abstract]   [Full Text] [Related]  

  • 5. Sigmoidal curve shift in idiopathic hypoparathyroidism and pseudohypoparathyroidism.
    Mizunashi K; Furukawa Y; Goto MM; Abe K
    Calcif Tissue Int; 1998 Apr; 62(4):290-4. PubMed ID: 9504951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pseudohypoparathyroidism: investigations of the serum parathyroid hormone level, pte resistance and urinary camp excretion before and during vitamin d treatment (author's transl)].
    Stögmann W
    Wien Klin Wochenschr Suppl; 1975; 33():1-15. PubMed ID: 176830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoparathyroidism and pseudohypoparathyroidism.
    Maeda SS; Fortes EM; Oliveira UM; Borba VC; Lazaretti-Castro M
    Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):664-73. PubMed ID: 17117292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An investigation of the biological activity of parathyroid hormone in pseudohypoparathyroidism: comparison with vitamin D deficiency.
    Allgrove J; Chayen J; Jayaweera P; O'Riordan JL
    Clin Endocrinol (Oxf); 1984 May; 20(5):503-14. PubMed ID: 6744632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolites and analogues of vitamin D. Which for what?
    Haussler MR; Cordy PE
    JAMA; 1982 Feb; 247(6):841-4. PubMed ID: 6895767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The vitamin D system: a view from basic science to the clinic.
    Deluca HF
    Clin Biochem; 1981 Oct; 14(5):213-22. PubMed ID: 7037225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of pseudohypoparathyroidism with 1 alpha-hydroxyvitamin D3.
    Furukawa Y; Sohn H; Unakami H; Yumita S
    Contrib Nephrol; 1980; 22():68-73. PubMed ID: 7398339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Difference in the therapeutic response to active vitamin D3 between PTH-deficient hypoparathyroidism and pseudohypoparathyroidism].
    Inoue D
    Clin Calcium; 2007 Aug; 17(8):1255-61. PubMed ID: 17660624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 25-Hydroxyvitamin D3 loading test in primary hyperparathyroidism, hypoparathyroidism and pseudohypoparathyroidism.
    Miura R; Furukawa Y; Yumita S; Sohn HE; Mizunashi K; Yoshinaga K
    Endocrinol Jpn; 1987 Feb; 34(1):97-104. PubMed ID: 3608916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Physiopathological and therapeutic aspects of vitamin D (author's transl)].
    Coen G; Bianchini G; Casciani CU
    Acta Vitaminol Enzymol; 1980; 2(3-4):103-18. PubMed ID: 7246390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypo-hyperparathyroidism: evidence for a defective parathyroid hormone.
    Connors MH; Irias JJ; Golabi M
    Pediatrics; 1977 Sep; 60(3):343-8. PubMed ID: 197477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial: The pieces of a vitamin D puzzle fall into place--almost!
    Wright DR
    N Engl J Med; 1975 Oct; 293(17):872-3. PubMed ID: 170517
    [No Abstract]   [Full Text] [Related]  

  • 17. Oral calcitriol versus oral alfacalcidol for the treatment of secondary hyperparathyroidism in patients receiving hemodialysis: a randomized, crossover trial.
    Moe S; Wazny LD; Martin JE
    Can J Clin Pharmacol; 2008; 15(1):e36-43. PubMed ID: 18192704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Parathyroid insufficiency syndrome. Two new cases: type Ia pseudohypoparathyroidism and pseudo-idiopathic hypoparathyroidism].
    Barajas de Frutos D; Pedrero Vera J; Bolívar Barrales JE; Espigares Martín R; Ortega Martos L; Vílchez Joya R; Bolívar Galiano V; Morell Bernabé JJ
    An Esp Pediatr; 1989 Oct; 31(4):385-8. PubMed ID: 2560613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic analysis of cinacalcet in combination with low-dose vitamin D versus flexible-dose vitamin D in treating secondary hyperparathyroidism in hemodialysis patients.
    Shireman TI; Almehmi A; Wetmore JB; Lu J; Pregenzer M; Quarles LD
    Am J Kidney Dis; 2010 Dec; 56(6):1108-16. PubMed ID: 20951487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factor-23 is regulated by 1alpha,25-dihydroxyvitamin D.
    Collins MT; Lindsay JR; Jain A; Kelly MH; Cutler CM; Weinstein LS; Liu J; Fedarko NS; Winer KK
    J Bone Miner Res; 2005 Nov; 20(11):1944-50. PubMed ID: 16234967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.